Cardiology Clinical Trials in Cincinnati, OH
As of August 2026, 49 paid clinical trials are recruiting for Cardiology in Cincinnati, Ohio. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Cincinnati
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
50 clinical trials for Cardiology
·Clear filters·A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
SELUTION 4 De Novo Small Vessel IDE Trial
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Prevail Global Study
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Transition to KPL-387 Monotherapy Dosing & Administration Study
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
PULSED AF Post-Approval Study
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
NORM-HF Pivotal Study
Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)
Aspiration Thrombectomy Using the Symphony or Prodigy System
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
Virtue® SAB in the Treatment of Coronary ISR Trial
The TRICURE EFS Study
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
BiVACOR® Total Artificial Heart Early Feasibility Study
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
The Fourth Left Atrial Appendage Occlusion Study
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Left vs Left Randomized Clinical Trial
Safety and Efficacy of FETO in CDH Phase III
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
Pulmonary Hypertension Association Registry
Top Research Study Locations in Cincinnati
Researchers run research studies in Cincinnati, OH at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cincinnati Children's Hospital Medical Center | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Neuroblastoma | 272 |
| University of Cincinnati | Chronic Lymphocytic Leukemia, Stroke, Multiple Myeloma | 100 |
| University of Cincinnati Medical Center | Advanced Solid Tumor, Interstitial Lung Disease, Stroke | 69 |
| Cincinnati Children's Hospital | Amblyopia, Musculoskeletal Pain, Acute Kidney Injury | 48 |
| University of Cincinnati Cancer Center-UC Medical Center | Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | 45 |
| The Christ Hospital | Heart Failure, Tricuspid Regurgitation, Advanced Solid Tumor | 40 |
| Bethesda North Hospital | Malignant Solid Neoplasm, Ovarian Carcinoma, Plasma Cell Myeloma | 31 |
| Good Samaritan Hospital - Cincinnati | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Anatomic Stage I Breast Cancer AJCC v8 | 31 |
| TriHealth Cancer Institute-Anderson | Malignant Solid Neoplasm, Ovarian Carcinoma, Plasma Cell Myeloma | 22 |
| TriHealth Cancer Institute-Westside | Malignant Solid Neoplasm, Ovarian Carcinoma, Plasma Cell Myeloma | 22 |
| CTI Clinical Research Center | Obesity, Overweight, Obstructive Sleep Apnea | 14 |
| Cincinnati Eye Institute | Stargardt Disease, Cone Rod Dystrophy, Juvenile Macular Degeneration | 14 |
| Oncology Hematology Care | Multiple Myeloma, Breast Cancer, Acute Myeloid Leukemia (AML) | 14 |
| Oncology Hematology Care Inc-Kenwood | Acral Lentiginous Melanoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 11 |
| University of Cincinnati College of Medicine | Acetabular Fracture, Acupuncture, Adolescents | 9 |
| Good Samaritan Hospital | Atrial Fibrillation, Chronic Subdural Hematoma, Deep Vein Thrombosis | 8 |
| University of Cincinnati Cancer Center | Colorectal Cancer, Anaplastic Lymphoma Kinase-positive, Cutaneous Melanoma | 8 |
| Cincinnati Childrens Hospital Medical Center | Adrenal Insufficiency, Alopecia, Areata Alopecia | 7 |
| Cinn Children Hosp Medical Center | Chronic Myelogenous Leukemia, Cryptosporidiosis, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive | 6 |
| GSK Investigational Site | Asthma, Chickenpox, Colonic Neoplasms | 6 |
| Oncology Hematology Care Clinical Trials, LLC | Carcinoma, Non-Small-Cell Lung, Chronic Graft-Versus-Host Disease (cGVHD), Esophageal Adenocarcinoma | 5 |
| Alkermes Investigational Site | Narcolepsy Type 1, Narcolepsy Type 2, Bipolar I Disorder | 5 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 5 |
| Children's Hospital Medical Center | Biliary Atresia, Duchenne Muscular Dystrophy, Essential Fatty Acid Deficiency | 5 |
| Christ Hospital | Acute or Chronic Coronary Artery Disease, Cardiovascular Diseases, Coronary Artery Disease | 5 |
Active & Upcoming Studies in Cincinnati (2026)
Recruiting trials in Cincinnati grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (284 active studies)
- A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer · Children's Hospital Medical Center, Cincinnati
- Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin · Phase 3 · NRG Oncology
Cardiovascular (91 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- Adapting Enhanced Supports to Improve Patient Adherence to Secondary Antibiotic Prophylaxis for Rheumatic Heart Disease · Children's Hospital Medical Center, Cincinnati
Neurology & pain (73 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy · Phase 2, Phase 3 · Jazz Pharmaceuticals
Diabetes & metabolic (36 active studies)
- GLP-1 RA for Stage 1 Type 1 Diabetes · Phase 2 · Children's Hospital Medical Center, Cincinnati
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
Pediatric (36 active studies)
- Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia · Children's Hospital Medical Center, Cincinnati
- Adapting Enhanced Supports to Improve Patient Adherence to Secondary Antibiotic Prophylaxis for Rheumatic Heart Disease · Children's Hospital Medical Center, Cincinnati
Mental health & behavior (23 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
Eye & vision (13 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
- A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · Astellas Pharma Global Development, Inc.
Vaccines (9 active studies)
- A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease · Phase 3 · Shionogi
- A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
HIV / STI (7 active studies)
- Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver) · Johns Hopkins University
- Health-E You Efficacy Trial for Male Adolescents · Johns Hopkins University
Common conditions studied in Cincinnati
- Heart Failure (19 active studies)
- Obesity (19 active studies)
- Overweight (12 active studies)
- Breast Cancer (11 active studies)
- Multiple Myeloma (11 active studies)
- Cystic Fibrosis (10 active studies)
Leading research sponsors in Cincinnati
- Children's Hospital Medical Center, Cincinnati
- University of Cincinnati
- National Cancer Institute (NCI)
- AstraZeneca
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Cincinnati?
There are approximately 1,080 recruiting clinical trials in Cincinnati, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Cincinnati pay participants?
Most recruiting trials in Cincinnati compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Cincinnati?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Cincinnati?
The most common conditions under active study in Cincinnati include Heart Failure (19), Obesity (19), Overweight (12), Breast Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Cincinnati?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Cincinnati on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Cincinnati?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Cincinnati?
Recruiting research sites in Cincinnati include Cincinnati Children's Hospital Medical Center, University of Cincinnati, University of Cincinnati Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Cincinnati right now?
The largest active categories in Cincinnati are Cancer & tumors (284), Cardiovascular (91), Neurology & pain (73). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.